Related Experiment Video
Updated: Aug 9, 2026
08:56
Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue
Published on: May 17, 2018
A comprehensive immunological analysis in chronic fatigue syndrome
1Division of Basic and Clinical Immunology, University of California, Irvine 92717.
Scandinavian Journal of Immunology
|March 1, 1991
Summary
Chronic fatigue syndrome (CFS) patients show reduced natural killer cells and impaired specific antibody responses, indicating immune system dysfunction. Further research is needed to understand the immunological basis of CFS.
Area of Science:
- Immunology
- Virology
Background:
- Chronic Fatigue Syndrome (CFS) is a complex condition with debated immunological underpinnings.
- Understanding immune system alterations in CFS is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate cell-mediated and antibody-mediated immunity in patients with CFS.
- To compare immune cell profiles and function between CFS patients and healthy controls.
Main Methods:
- Analysis of lymphocyte subsets (CD3+, CD4+, CD8+, CD20+, CD16+, CD56+, CD57+).
- Assessment of monocyte adhesion molecule expression (ICAM-1, LFA-1) and interferon-gamma response.
- Evaluation of lymphocyte DNA synthesis and in vivo antibody response to pneumococcus vaccine.
- Measurement of serum immunoglobulin levels and anti-HHV-6 antibody titers.
Main Results:
- CFS patients exhibited significantly reduced natural killer cells and increased CD4+ ICAM-1+ T cells.
- Monocytes in CFS showed altered ICAM-1 and LFA-1 expression and reduced response to interferon-gamma.
- Impaired in vivo specific antibody response to pneumococcus vaccine was observed in CFS patients.
- Elevated anti-HHV-6 antibody titers were found in 40% of CFS patients.
Conclusions:
- The study suggests significant immunological dysfunction in CFS patients.
- Specific deficits in natural killer cell function and antibody production point to immune system abnormalities in CFS.
